RHY – Rhythm Biosciences | Aussie Stock Forums

“It is a very exciting time for the Company. We are buoyed with the significant progress we have made with the core technology. A considerable amount of work has gone into selecting, screening, optimising and now technically validating the antibodies for the biomarkers that we expect will make up the final ColoSTAT® test-kit” Rhythm CEO, Glenn Gilbert said.